Hum Vaccin Immunother
-
Publication Venue For
- Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants.. 18:1908030. 2022
- Predictive factors of neoadjuvant immune checkpoint blockade in melanoma.. 18:1943987. 2022
- Key stakeholder perspectives on challenges and opportunities for rural HPV vaccination in North and South Carolina.. 1-8. 2022
- Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States.. 17:5390-5396. 2021
- Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice.. 17:4144-4154. 2021
- Disparities in human papillomavirus (HPV) vaccine initiation and completion based on sexual orientation among women in the United States.. 17:428-433. 2021
- Emerging immunotherapies for autoimmune kidney disease.. 15:876-890. 2019
- Evaluation of two frailty indices, with practical application in a vaccine clinical trial.. 15:2960-2968. 2019
- Provider-level rates of HEDIS-consistent HPV vaccination in a regional health plan.. 15:1708-1714. 2019
- There's Much Yet to be Done: Diverse Perspectives on HPV Vaccination.. 15:1459-1464. 2019
- Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States.. 14:2016-2024. 2018
- Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines.. 13:2996-3009. 2017
- Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine.. 13:2713-2722. 2017
- Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV.. 13:2726-2737. 2017
- Effect of antipyretic analgesics on immune responses to vaccination.. 12:2391-2402. 2016
- Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus.. 11:504-515. 2015
- Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques.. 9:2081-2094. 2013
- Vaccination with Vaxfectin(®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia.. 9:2069-2080. 2013
- High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088).. 9:957-968. 2013
- Vaccination against herpes zoster in developed countries: state of the evidence.. 9:1177-1184. 2013
- IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques.. 8:1620-1629. 2012
- Future therapies for food allergy.. 8:1479-1484. 2012
- Importance of neutralization sieve analyses when seeking correlates of HIV-1 vaccine efficacy.. 10:2507-2511. 2014
- Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity. 2020